Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Saline flushing of the pleural space using a new irrigation device

Official title: A Pilot Assessment of the Safety and Efficacy of Pleural Irrigation for Retained Pleural Infection Using a Novel Irrigation Device

Run by Beth Israel Deaconess Medical Center · NCT06727578 · Data updated 2026-11-12

This pilot tests whether flushing the pleural space with sterile saline using the CLR irrigator can help clear retained infected pleural fluid in patients who cannot receive standard intrapleural enzyme therapy.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment10 (estimated)
SponsorBeth Israel Deaconess Medical Center
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedMay 25, 2025
Main results expectedMay 25, 2027
Study endsJuly 31, 2027
Registry record updatedAugust 27, 2026
Trial IDNCT06727578 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with retained infected pleural fluid seen on bedside ultrasound within 24 hours after chest tube placement who cannot receive intrapleural enzymatic therapy are the intended candidates.

Probably not a fit

Patients with pleural fluid from non-infectious causes (for example malignancy) or with post-procedural empyema or complicated parapneumonic effusion are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-arm pilot in which patients with retained pleural effusion identified by bedside ultrasound within 24 hours of chest tube insertion receive intrapleural saline irrigation delivered with the CLR irrigator. The trial enrolls patients who are contraindicated for intrapleural enzymatic therapy and excludes non-infectious effusions and post-procedural empyema. Key outcomes include radiographic and clinical clearance of retained fluid, need for additional invasive procedures, and safety/tolerability. The procedure is performed and monitored at Beth Israel Deaconess Medical Center.

Why it matters

Potential benefit: If successful, this approach could clear infected pleural collections without enzymatic therapy and reduce the need for additional invasive procedures.

How similar studies have gone: Intrapleural enzymatic therapy (tPA/DNase) has demonstrated benefit in pleural infection, but saline irrigation with the CLR device is a novel approach with limited prior data and is being tested here as a pilot.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Retained pleural effusion identified via bedside ultrasound within the first 24 hours after chest tube insertion
* Patient is contraindicated from receiving intrapleural enzymatic therapy within the first 24 hours after chest tube insertion

Exclusion Criteria:

* Non-infectious cause of pleural fluid analysis findings listed above identified (e.g. malignancy)
* Post-procedural empyema or complicated parapneumonic effusion

Where it's running

  • Beth Israel Deaconess Medical Center
    Boston, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.